Study summary · 2025 · Evidence review
Telehealth costs during the COVID-19 pandemic
Patient costs may fall with telehealth, but effects on total spending remain uncertain and application-specific.
Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence
Original publication
The Effect of Telehealth on Cost of Health Care During the COVID-19 Pandemic: A Systematic Review
Lauren Lavin; Heath Gibbs; J Priyanka Vakkalanka; Sara Ternes; Heather S Healy; Kimberly A S Merchant; Marcia M Ward; Nicholas M Mohr
University of Iowa: College of Public Health, Carver College of Medicine and Hardin Library for the Health Sciences, United States
Telemedicine and e-Health · Online: · Issue: March 2025
Final journal abstract; online November 18, 2024; March 2025 issue, volume 31(3), pages 310–319. A separate November 2024 research brief updates the search and is not treated as this article. · Summary limited to the accessible abstract.
What was studied
- Design
- Evidence review
- Population
- Patients using telehealth during the COVID-19 public health emergency
- Sample
- 12 included studies from 8,557 screened records
- Intervention
- Telehealth applications of varying modalities
- Comparator
- Study-specific cost comparisons
- Follow-up
- No common duration reported in the accessible abstract
- Review search cutoff
- 2023-05-26
- Setting
- Multiple countries; detailed distribution not available in the abstract
Methods
Four-database systematic review, supplemented by government and rural-health website searches in June 2023. Costs were separated into patient, payer and health-sector perspectives.
Findings
The abstract reports increased telehealth spending alongside lower patient costs and limited changes in monthly total spending. Results differed by application; no pooled monetary estimate or confidence interval is supplied.
Limitations
Abstract-only appraisal: detailed costing assumptions and individual estimates were unavailable. Included studies had heterogeneous modalities and cost definitions and, on average, moderate bias risk.
What this means for care delivery
Patient savings do not establish payer or health-system savings. This source cannot supply a transferable return-on-investment estimate.